You are using an older browser version. Please use a supported version for the best MSN experience.

SYNLOGIC, INC

NASDAQ: SYBX
7.82
+0.10
+1.30%

Sector

Healthcare

Industry

Pharmaceuticals

Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.

Key People

Michael Powell

Chairman of the Board

Aoife Brennan

President, Chief Executive Officer, Director

Todd Shegog

Chief Financial Officer, Secretary

Andrew Gengos

Chief Operating Officer - Head of Corporate Development

Paul Miller

Chief Scientific Officer

Incorporated

2007

Employees

74

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 2/12/2019

    • MILLER PAUL FRANCIS

    • Sold

    • 9,000

    • 9.75

    • 87,750.00

    • 10/18/2018

    • MILLER PAUL FRANCIS

    • Sold

    • 3,000

    • 9.77

    • 29,295.90

    • 9/18/2018

    • MILLER PAUL FRANCIS

    • Sold

    • 3,000

    • 13.05

    • 39,162.90

    • 9/5/2018

    • MILLER PAUL FRANCIS

    • Sold

    • 3,000

    • 12.55

    • 37,635.30

    • 8/29/2018

    • MILLER PAUL FRANCIS

    • Sold

    • 3,000

    • 9.77

    • 29,309.40

    • 7/18/2018

    • MILLER PAUL FRANCIS

    • Sold

    • 3,000

    • 11.01

    • 33,021.90

    • 6/19/2018

    • MILLER PAUL FRANCIS

    • Sold

    • 3,000

    • 9.80

    • 29,400.00

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 2/12/2019

      • MILLER PAUL FRANCIS

      • Sold

      • 9,000

      • 9.75

      • 87,750.00

      • 10/18/2018

      • MILLER PAUL FRANCIS

      • Sold

      • 3,000

      • 9.77

      • 29,295.90

      • 9/18/2018

      • MILLER PAUL FRANCIS

      • Sold

      • 3,000

      • 13.05

      • 39,162.90

      • 9/5/2018

      • MILLER PAUL FRANCIS

      • Sold

      • 3,000

      • 12.55

      • 37,635.30

      • 8/29/2018

      • MILLER PAUL FRANCIS

      • Sold

      • 3,000

      • 9.77

      • 29,309.40

      • 7/18/2018

      • MILLER PAUL FRANCIS

      • Sold

      • 3,000

      • 11.01

      • 33,021.90

      • 6/19/2018

      • MILLER PAUL FRANCIS

      • Sold

      • 3,000

      • 9.80

      • 29,400.00

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon